Moderna gets $50M investment for Ebola vaccine candidate
Global health foundation Coalition for Epidemic Preparedness Innovations (CEPI) will invest $50 million to support development and initial clinical testing of Moderna's investigational vaccine against the Bundibugyo strain of Ebola, the deadly virus ripping through parts of the Democratic Republic of Congo. If early data are positive, the funding would also support manufacturing and progression to later-stage…
Global health foundation Coalition for Epidemic Preparedness Innovations (CEPI) will invest $50 million to support development and initial clinical testing of Moderna's investigational vaccine against the Bundibugyo strain of Ebola, the deadly virus ripping through parts of the Democratic Republic of Congo. If early data are positive, the funding would also support manufacturing and progression to…
Global health foundation Coalition for Epidemic Preparedness Innovations (CEPI) will invest $50 million to support development and initial clinical testing of Moderna's investigational vaccine against the Bundibugyo strain of Ebola, the deadly virus ripping through parts of the Democratic Republic of Congo. If early data are positive, the funding would also support manufacturing and progression to later-stage…
The full story continues on The Hill.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.